Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at DeepMind Blog.
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
arXiv:2609.15285v1 Announce Type: new Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease in which early assessment remains challenging, particularly in low-resou...
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.
arXiv:2606. 07562v1 Announce Type: cross Abstract: RNA design consists of discovering a nucleotide sequence that optimizes predefined criteria, such as secondary structure.
arXiv:2505.23862v2 Announce Type: replace-cross Abstract: The mRNA optimization is essential for mRNA vaccines, therapies, and industrial protein production. Based on current explorations, an ideal o...
Explore how AlphaFold has accelerated science and fueled a global wave of biological discovery.
